Arik Hasson

Title: Inventor Profile: Arik Hasson

Introduction: Arik Hasson is a notable inventor based in Jerusalem, Israel. With a focus on innovative peptides, Hasson's work has contributed significantly to the field of biochemistry, particularly in relation to sodium channels and conotoxin peptides.

Latest Patents: Arik Hasson holds a patent for his invention regarding conotoxin peptides, which are crucial in the modulation of sodium channels. This patent includes peptides comprising 25-35 amino acids that exhibit unique structural properties, characterized by the presence of six cysteines forming three disulfide bonds. Specifically, the patent highlights the .delta.-conotoxin GmVIA and .mu.O-conotoxin peptides, which are valuable for their abilities to activate and block sodium channels, respectively.

Career Highlights: Throughout his career, Arik Hasson has made significant strides in research and development. He has contributed to the University of Utah Research Foundation and Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. These positions have allowed him to collaborate on pivotal projects that explore the therapeutic potentials of conotoxin peptides.

Collaborations: Arik Hasson has worked closely with esteemed colleagues such as Ki-Joon Shon and Baldomero M. Olivera. Their collaborative efforts have furthered the understanding and application of conotoxins in scientific research, enhancing the potential for novel medical treatments.

Conclusion: Arik Hasson's contributions through his patent on conotoxin peptides mark a significant advancement in biochemistry. His innovative work holds promise for future research and therapeutic applications in the field of neuroscience and beyond, showcasing the impact that dedicated inventors can have on scientific progress.